- Filed
- Nov 4, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 28, 2025 | 154.88M sh |
| Stock Issued | Q3 2025 · Sep 27, 2025 | 130.07K sh |
| Stock Issued | Q3 2025 · Jun 28, 2025 | 78.97K sh |
| Stock Issued | Q3 2025 · Mar 29, 2025 | 452.44K sh |
| Stock Issued | Q3 2025 · Sep 28, 2024 | 239.39K sh |
| Stock Issued | Q3 2025 · Jun 29, 2024 | 102.92K sh |
| Stock Issued | Q3 2025 · Mar 30, 2024 | 303.01K sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 151.96M sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 151.8M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 151.47M sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 151.18M sh |
| Stock Repurchased | Q3 2025 · Sep 27, 2025 | $2.2M |
| Stock Repurchased | Q3 2025 · Sep 27, 2025 | $14.7M |
| Stock Repurchased | Q3 2025 · Sep 28, 2024 | $2.3M |
| Stock Repurchased | Q3 2025 · Sep 28, 2024 | $10M |
| Dividends Paid | Q3 2025 · Sep 27, 2025 | $125.8M |
| Dividends Paid | Q3 2025 · Sep 27, 2025 | $374.3M |
| Dividends Paid | Q3 2025 · Sep 28, 2024 | $123.6M |
| Dividends Paid | Q3 2025 · Sep 28, 2024 | $367.2M |
| Capex | Q3 2025 · Sep 27, 2025 | $65.9M |
| Capex | Q3 2025 · Sep 27, 2025 | $210.5M |
| Capex | Q3 2025 · Sep 28, 2024 | $86.5M |
| Capex | Q3 2025 · Sep 28, 2024 | $239.4M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $221.2M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $15.5M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $285.8M |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $427.8M |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $4.7B |
| Long Term Debt | Q3 2025 · Dec 28, 2024 | $5.6B |
| Short Term Debt | Q3 2025 · Sep 27, 2025 | $1.36B |
| Short Term Debt | Q3 2025 · Dec 28, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $268.3M |
| Cash And Equivalents | Q3 2025 · Dec 28, 2024 | $290.5M |
| Stockholders Equity | Q3 2025 · Sep 27, 2025 | $8.98B |
| Stockholders Equity | Q3 2025 · Jun 28, 2025 | $9.06B |
| Stockholders Equity | Q3 2025 · Mar 29, 2025 | $8.84B |
| Stockholders Equity | Q3 2025 · Dec 28, 2024 | $8.72B |
| Stockholders Equity | Q3 2025 · Sep 28, 2024 | $8.86B |
| Stockholders Equity | Q3 2025 · Jun 29, 2024 | $8.72B |
| Stockholders Equity | Q3 2025 · Mar 30, 2024 | $8.88B |
| Stockholders Equity | Q3 2025 · Dec 30, 2023 | $9.06B |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $5.86B |
| Current Liabilities | Q3 2025 · Dec 28, 2024 | $4.92B |
| Current Assets | Q3 2025 · Sep 27, 2025 | $6.5B |
| Current Assets | Q3 2025 · Dec 28, 2024 | $6.38B |
| Total Assets | Q3 2025 · Sep 27, 2025 | $21.75B |
| Total Assets | Q3 2025 · Dec 28, 2024 | $21.85B |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.34 |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $1.61 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.60 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.66 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.34 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $1.61 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.61 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.66 |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $789.7M |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $2.51B |
| Sga Expense | Q3 2025 · Sep 28, 2024 | $790M |
| Sga Expense | Q3 2025 · Sep 28, 2024 | $2.47B |
| Net Income | Q3 2025 · Sep 27, 2025 | $51.4M |
| Net Income | Q3 2025 · Sep 27, 2025 | $243.7M |
| Net Income | Q3 2025 · Jun 28, 2025 | $101.9M |
| Net Income | Q3 2025 · Mar 29, 2025 | $90.4M |
| Net Income | Q3 2025 · Sep 28, 2024 | $91.1M |
| Net Income | Q3 2025 · Sep 28, 2024 | $99.4M |
| Net Income | Q3 2025 · Jun 29, 2024 | −$11.2M |
| Net Income | Q3 2025 · Mar 30, 2024 | $19.5M |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $2.58B |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $8.08B |
| Cost Of Revenue | Q3 2025 · Sep 28, 2024 | $2.63B |
| Cost Of Revenue | Q3 2025 · Sep 28, 2024 | $8.27B |
| Revenue | Q3 2025 · Sep 27, 2025 | $3.76B |
| Revenue | Q3 2025 · Sep 27, 2025 | $11.45B |
| Revenue | Q3 2025 · Sep 28, 2024 | $3.75B |
| Revenue | Q3 2025 · Sep 28, 2024 | $11.65B |